A pilot study of copper supplementation effects on plasma F2α isoprostanes and urinary collagen crosslinks in young adult women

Journal of Trace Elements in Medicine and Biology

Volumn 24, Issue 3, 2010, Pages 165-168

  DiSilvestro, Robert A ^a   Selsby, Joshua ^b   Siefker, Kristina ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Bone; Copper; Crosslinks; Isoprostanes; Supplementation

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; AMINE OXIDASE (COPPER CONTAINING); CERULOPLASMIN; COLLAGEN; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; ISOPROSTANE; PLACEBO;

ADULT; ALPHA HELIX; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS LINKING; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; URINALYSIS;

ADOLESCENT; AMINE OXIDASE (COPPER-CONTAINING); CERULOPLASMIN; COLLAGEN; COPPER; CROSS-LINKING REAGENTS; DIETARY SUPPLEMENTS; ERYTHROCYTES; F2-ISOPROSTANES; FEMALE; HUMANS; PILOT PROJECTS; PLACEBOS; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 77953537382     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2010.02.003     Document Type: Article

References (19)

1. DiSilvestro R.A. Handbook of minerals as nutritional supplements 2005, CRC Press, Boca Raton.
2. Wardlaw G.M., Hampl J.S., DiSilvestro R.A. Perspectives in nutrition 2004, McGraw-Hill, New York. 6th ed.
3. Lukaski HC, Johnson PE. Dietary copper (Cu) at the recommended intake decreases muscle cytochrome c oxidase (CCO) activity and alters metabolic responses during exercise in men. FASEB J 2005;19:A982.
4. Jones A.A., DiSilvestro R.A., Coleman M., Wagner T.L. Copper supplementation of adult men: effects on blood copper enzyme activities & indicators of cardiovascular disease risk. Metabolism 1997, 46:1380-1383.
5. DiSilvestro R.A., Marten J.T., Skehan M. Effects of copper supplementation on ceruloplasmin and copper-zinc superoxide dismutase activities in free-living rheumatoid arthritis patients. J Am Coll Nutr 1992, 11:177-180.
6. Kehoe C.A., Turley E., Bonham M.P., O'Connor J.M., McKeown A., Faughnan M.S., Coulter J.S., Gilmore W.S., Howard A.N., Strain J.J. Response of putative indices of copper status to copper supplementation in human subjects. Br J Nutr 2000, 84:151-156.
7. Klevay L.M., Inman L., Johnson L.K., Lawler M., Mahalko J.R., Milne D.B., Lukaski H.C., Bolonchuk W., Sandstead H.H. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism 1984, 33:1112-1118.
8. Reiser S., Powell A., Yang C.Y., Canary J.J. Effect of copper intake on blood cholesterol and its lipoprotein distribution in man. Nutr Rep Int 1987, 36:641-646.
9. Reiser S., Smith J., Mertz W. Indices of copper status in humans consuming a typical American diet containing either fructose or starch. Am J Clin Nutr 1985, 42:242-251.
10. Davis C.D. Low dietary copper increases fecal free radical production, fecal water alkaline phosphatase activity and cytotoxicity in healthy men. J Nutr 2003, 133:522-527.
11. Howell J.M.C., Gawthorne J.M. Copper in animals and man 1987, CRC Press, Boca Raton.
12. Strause L., Saltman P., Smith K.T., Bracker M., Andon M.B. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J. Nutr 1994, 124:1060-1064.
13. Darden A.G., Ries W.L., Wolf W.C., Rodriguiz R.M., Key L.L. Osteoclastic superoxide production and bone resorption: stimulation and inhibition by modulators of NADPH oxidase. J Bone Miner Res 1996, 11:671-675.
14. DiSilvestro R.A., Marten J.T. Effects of inflammation and copper intake on rat liver and erythrocyte Cu-Zn superoxide dismutase activity levels. J Nutr 1990, 120:1223-1227.
15. Morrow J.D. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 2005, 25:279-286.
16. Sutherland W.H.F., Manning P.J., Walker R.J., de Jong S.A., Ryalls A.R., Berry E.A. Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects. Obesity 2007, 15:386-391.
17. Christmas C., O'Connor K.G., Harman S.M., Tobin J.D., Münzer T., Bellantoni M.F., Clair C.S., Pabst K.M., Sorkin J.D., Blackman M.R. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. J Gerontol A Biol Sci Med Sci 2002, 57:M12-M18.
18. Yasunori K., Masaaki T., Tetsuyuki N., Hayato K., Akira N. Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis. Clin Rheumatol 2008, 27:1093-1101.
19. Denk E., Hillegonds D., Hurrell R.F., Vogel J., Fattinger K., Häuselmann H.J., Kraenzlin M., Walczyk T. Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass. J Bone Miner Res 2007, 22:1518-1525.